期刊文献+

老年原发性胆汁性肝硬化患者抗核抗体特征分析

Profiles of antinuclear antibodies in senile primary biliary cirrhosis patients
下载PDF
导出
摘要 目的分析抗核抗体在老年原发性胆汁性肝硬化(PBC)患者的表现特征。方法应用间接免疫荧光检测70例老年PBC患者及360例对照者的血清抗核抗体(ANA),并应用免疫印迹法检测其抗线粒体抗体M2亚型(AMA-M2)、抗核点型SP100抗体、抗核膜型gp210抗体。结果70例老年PBC患者中有66例ANA阳性(94%),其中43例表现为混合荧光模式。AMA-M2检出率为90%。ANA主要荧光模式对老年PBC患者敏感性88%(62/70),特异性为91.6%(330/360),83.3%ANA滴度≥1:1000,与对照组比较差异有统计学意义(P〈0.01)。结论老年PBC患者ANA的荧光模型主要为核膜型、核点型、着丝点型、胞浆颗粒型,常表现为混合荧光模型,对于老年PBC具有重要的诊断价值。 Objective To analyze the profiles ofantinuclear antibody(ANA) in senile primary biliary cirrhosis(PBC) patients. Methods Indirect immunofluorescence was used to test ANA in the serum samples of 70 senile PBC patients and of 360 aged-matched controls, including 120 health individuals, 80 patients with viral hepatitis, 40 with reumatoid arthritis, 30 with autoimmune hepatitis, 30 with mixed connective tissue disease, 30 with systemic lupus erythematosus, and 30 with systemic sclerosis. Immunoblot analysis was applied to examine AMA-M2, antinuclear dots pattern SP100 antibody and antinuclear membrane pattern gp210 antibody. Results In the 70 senile PBC patients, there were 66 positive with ANA (94%), with 43 cases of mixed immunofluorescence patterns. The positivity rate of AMA-M2 was 90%. For major immunofluorescence patterns of ANA in the senile PBC, the sensitivity was 88% (62/70), and the specificity was 91.6% (330/360). More over, 83.3% of senile PBC patients had ANA titer ≥1 : 1000, which was significantly different from the controls (P 〈 0.01) Conclusion Immunofluorescence patterns of ANA in senile PBC patients are nuclear membrane pattern, nuclear dots pattern, centromere pattern and cytoplasm speckled pattern, and they usually present as mixed immunofluorescence pattern. ANA is of great value in the diagnosis of senile PBC.
出处 《中华老年多器官疾病杂志》 2012年第12期889-892,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 老年人 肝硬化 胆汁性 抗体 抗核 荧光模型 elderly cirrhosis, biliary antibody, antinuclear immunofluorescence patterns
  • 相关文献

参考文献15

  • 1Pares A,Rodes J. Natural history of primary biliary cirrhosis[J].Clinics in Liver Disease,2003,(04):779-794.doi:10.1016/S1089-3261(03)00100-4.
  • 2Floreani A,Chiaramonte M,Fabris P. Primary biliary cirrhosis in the elderly[J].Recenti Progress in Medicina,1991,(05):259-261.
  • 3Lindor KD,Gershwin ME,Poupon R. Primary biliary cirrhosis[J].Hepatology,2009,(01):291-308.doi:10.1002/hep.22906.
  • 4张福奎,贾继东,王宝恩.老年人原发性胆汁性肝硬化的临床特征[J].中华老年医学杂志,2005,24(1):18-20. 被引量:9
  • 5张铭明,张锐.原发性胆汁性肝硬化患者抗核抗体特殊荧光模型分析及诊断价值[J].临床检验杂志,2010,28(2):122-123. 被引量:5
  • 6冯霞,闫惠平,刘妍,刘燕敏,檀玉芬,唐乐,马冬梅.58例原发性胆汁性肝硬化患者抗线粒体抗体和抗核抗体的特征分析[J].检验医学,2006,21(2):106-109. 被引量:7
  • 7Gao L,Tian X,Liu B. The value of antinuclear antibodies in primary biliary cirrhosis[J].Clinical and Experimental Medicine,2008,(01):9-15.
  • 8Milkiewicz P,Buwaneswaran H,Coltescu C. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease[J].Clinical Gastroenterology and Hepatology,2009,(12):1355-1360.
  • 9Bogdanos DP,Vergani D,Muratori P. Specificity of anti-sp100 antibody for primary biliary cirrhosis[J].Scandinavian Journal of Gastroenterology,2004,(04):405-406,407.
  • 10Salliot C,Gottenberg JE,Bengoufa D. Anticentromere antibodies identify patients with Sjogren's syndrome and autoimmune overlap syndrome[J].Journal of Rheumatology,2007,(11):2253-2258.

二级参考文献25

  • 1刘燕敏,闫惠平,汪俊韬.肝功能异常患者中自身抗体及自身免疫性肝病的检测[J].中华肝脏病杂志,2004,12(6):360-362. 被引量:47
  • 2李新民,马雄,邱德凯.自身免疫性肝病临床及免疫学特征[J].肝脏,2006,11(4):244-246. 被引量:4
  • 3Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31: 929-938.
  • 4Joshi S, Cauch-Dudek K, Wanless IR, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology, 2002, 35:409-413.
  • 5Lohse AW, zum Biischenfelde KH, Franz B, et al. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology, 1999, 29: 1078- 1084.
  • 6Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges. Gastroenterology, 2001, 120:1502-1517.
  • 7Czaja AJ. Treatment of autoimmune hepatitis. Semin Liver Dis, 2002, 22: 365-378.
  • 8Durazzo M, Premoli A, Fagoonee S, et al. Overlap syndromes of autoimmune hepatitis: what is known so far. Dig Dis Sci, 2003, 48: 423-430.
  • 9Heathcote EJ. Management of primary biliary cirrhosis[ J]. Hepatology, 2000, 31(4) :1005-1013.
  • 10Invernizzi P, Selmi C, Ranftler C, et al. Antinuclear antibodies in primary biliary cirrhosis [ J 1. Semin Liver Dis,2005, 25 ( 3 ) : 298-310.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部